Skip to main content
Clinical Trials/NCT00897117
NCT00897117
Recruiting
Not Applicable

Molecular Fingerprinting of Lung Cancer

Vanderbilt-Ingram Cancer Center3 sites in 1 country4,000 target enrollmentMay 1, 2001
ConditionsLung Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Vanderbilt-Ingram Cancer Center
Enrollment
4000
Locations
3
Primary Endpoint
Protein and RNA expression fingerprints from collected samples
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer.

PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.

Detailed Description

OBJECTIVES: * Develop statistical and computational methods for modeling the relationships between multiple variable protein and RNA expression data and clinical endpoints using both supervised and unsupervised classification and pattern recognition approaches. * Determine protein and RNA expression fingerprints on completely resected non-small cell lung cancer without prior chemotherapy. * Correlate protein and RNA expression fingerprints with T-stage and nodal involvement at the time of surgery, and collect outcome data to allow correlation with recurrence (local and/or distant) and survival. OUTLINE: This is a multicenter study. Any excess tissues removed from surgery and would otherwise be discarded (tissues not used for diagnosis and/or treatment decision making) are obtained for this study. Tissue are analyzed for molecular features that predict biologic behavior. Quantitation of RNA, gene expression profiles, and protein expression patterns are assessed by matrix-assisted laser desorption/ionization time of flight mass spectroscopy and microarray analysis. Medical records are reviewed to obtain information about results of tests associated with cancer diagnosis. Further progress in cancer treatment and tumor behavior after surgery are followed via record review.

Registry
clinicaltrials.gov
Start Date
May 1, 2001
End Date
May 31, 2031
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric Grogan

Associate Professor of Thoracic Surgery

Vanderbilt-Ingram Cancer Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Protein and RNA expression fingerprints from collected samples

Time Frame: after collection of designated samples

Secondary Outcomes

  • Development of statistical and computational methods to model relationship of data and clinical outcomes(after laboratory gene analysis work is completed)
  • Correlation of protein and RNA expression fingerprints with recurrence (local and/or distant) and survival(after collection of designated samples)

Study Sites (3)

Loading locations...

Similar Trials